Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

Young or old, strengthen your bones and joints with these calcium supplements. They can help to prevent deficiencies and ...

Zoldonrasib showed a 61% objective response rate and 89% disease control rate in NSCLC patients at 1200 mg QD. Most treatment-related side effects were mild, with a 98% mean dose intensity and no ...

One representative called it a “wonderful, reefer-smelling bag” and another worried a drug-sniffing dog might alert to him at ...

Instead, you can add alternatives to address this concern. Dairy products like cheese, milk cause stomach issues in ...

Coupled with the cup of coffee he’d had earlier, he may have ingested about 600 milligrams of caffeine in an hour. While the ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

He said a typical hemp product in his store contains between 200 to 1,200 milligrams per package, with a varying number of servings. For example, one product had 200 total milligrams listed on the ...

unresponsive to antihistamines at a dosage of 1200 mg/d compared with placebo. Researchers conducted a 52-week phase 2 trial comprising a 12-week double-blind, placebo-controlled period followed ...

While the FDA estimates that toxic effects can occur with the rapid consumption of about 1,200 milligrams—which may cause heart palpitations, high blood pressure, and an increased heart rate ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.